Recent advances in ischaemic heart disease.
There continue to be important developments in the understanding of the pathogenesis of coronary artery disease. Advances have also been made in both the medical and interventional management of patients with ischaemic heart disease. This review has, however, not focused on the wider developments that have occurred in the area of percutaneous intervention. The vast array of new stent designs and other interventional devices have had a considerable impact on the treatment of obstructive coronary disease. In addition it is likely that further developments will be seen in areas such as intracoronary radiotherapy to reduce restenosis after PTCA and in gene therapy to promote angiogenesis in ischaemic myocardium. Both of which will be discussed in a future review of this area.
Cusack
M
M
Cardiothoracic Unit, St Thomas' Hospital, London SE1 7EH, UK. michael.cusack@kcl.ac.uk
Redwood
S
S
Coltart
J
J
D000787:Angina Pectoris / Q000601:surgery; D003324:Coronary Artery Disease / Q000209:etiology; D006801:Humans; D007249:Inflammation / Q000150:complications; D053685:Laser Therapy; D017202:Myocardial Ischemia / Q000209:etiology* / Q000628:therapy*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors
D019039:Platelet Glycoprotein GPIIb-IIIa Complex